TSW
TXG icon

Three Seasons Wealth’s 10x Genomics TXG Stock Holding History

Three Seasons Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+5,423
New +$142K 0.02% 171
2025
Q2 		– Sell
-30,948
Closed -$270K – 127
2025
Q1 		$270K Hold
30,948
– – 0.13% 92
2024
Q4 		$444K Buy
+30,948
New +$488K 0.22% 87

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Three Seasons Wealth's TXG Position: Q2 2026 in Review

Three Seasons Wealth opened a new position in 10x Genomics (TXG) in Q2 2026: 5,423 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #171 among its holdings. This is a return to the name: Three Seasons Wealth previously reported a position in TXG as recently as Q1 2025.

Three Seasons Wealth first reported a position in TXG in Q4 2024 and has held it in 3 quarters since. The position peaked at $444K in Q4 2024. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Three Seasons Wealth held 5,423 shares of 10x Genomics worth $208K as of Q2 2026.
  • 10x Genomics was a new Three Seasons Wealth position in Q2 2026.
  • 10x Genomics made up 0.02% of Three Seasons Wealth's portfolio in Q2 2026, its #171 holding.
  • Three Seasons Wealth first reported a position in 10x Genomics in Q4 2024 and has held it in 3 quarters since.
  • Three Seasons Wealth's 10x Genomics position peaked at $444K in Q4 2024.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.